What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2025-07-15 compared with 2024-06-28 · 13 added, 34 removed, 5 unchanged (90% of the section changed)

2 unchanged sentences

Market Information

Our common stock commenced trading on the Nasdaq

Capital Market on June 6, 2024 under the symbol FLYE.

As of June 27, 2024, we had 12 stockholders of record.

Our common stock commenced

trading on the Nasdaq Capital Market on June 6, 2024 under the symbol “FLYE”.

As of July 15, 2025, we

had 26 stockholders of record.

Transfer Agent

Transfer, LLC, 18 Lafayette Place, Woodmere, New York 11598, is the transfer agent for our common stock.

We have never declared or paid any cash or other

dividends or distributions on our capital stock.

We currently intend to retain earnings, if any, to finance the growth and development

of our business.

VStock Transfer, LLC, 18

Lafayette Place, Woodmere, New York 11598, is the transfer agent for our common stock.

We have never declared or

paid any cash or other dividends or distributions on our capital stock.

We currently intend to retain earnings, if any, to finance the

growth and development of our business.

We do not expect to pay any cash dividends on our common stock in the foreseeable future.

Payment of future dividends,

if any, will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital

requirements, restrictions contained in any financing instruments, provisions of applicable law and other factors the board deems relevant.

Use of Proceeds from Our Initial Public Offering

On June 7, 2024, we closed our IPO of 2,250,000 shares of our common

stock at the price of $4.00 per share, resulting in net proceeds to us of $7.9 million after deducting underwriting discounts and commissions

and offering expenses.

On June 25, 2024, we sold an additional 337,500 shares of common stock to the underwriters of our IPO for gross

proceeds of $1.4 million upon full exercise of the underwriters’ over-allotment option.

All of the shares issued and sold in our

IPO were registered under the Securities Act pursuant to a registration statement on Form S-1, as amended (File No.

333-276830), which

was declared effective by the Securities and Exchange Commission on May 14, 2024.

The Benchmark Company, LLC acted as representative of

the underwriters.

We paid the underwriters in aggregate approximately $0.7 million in underwriting commissions and incurred offering expenses

of approximately $0.3 million.

No payments for such expenses were made to our directors or officers or their associates, holders

of 10% or more of any class of our equity securities, or to our affiliates.

There has been no material change in the planned use of proceeds

from our IPO from those disclosed in the Final Prospectus.

No proceeds were used for the year ended March 31, 2024.

As of June 27, 2024,

we used approximately $4.2 million, $0.2 million, and $1.1 million for purchase of inventory and production costs, software development,

and working capital, respectively.

The balance is being held in short-term interest-bearing deposits and securities.

of future dividends, if any, will be at the discretion of our board of directors and will depend on our financial condition, results

of operations, capital requirements, restrictions contained in any financing instruments, provisions of applicable law and other factors

the board deems relevant.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity